LONGBIO-B 01779Hong Kong Stock Exchange

98.0003.16%( +3.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
LONGBIO-B (01779) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
LongBio Pharma (Suzhou) Co., Ltd.
Market
HKEX Main Board
Listing Date
2026-06-05
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007NF2

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Net Profit (Last FY)-205.90M77/125
ROE (Last FY)-124.96%113/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
刘恒 Executive Director
孙乃超 Executive Director
谢鸣 Executive Director
蔺剑 Non-Executive Director
顾勤 Non-Executive Director
薛涤 Non-Executive Director
薛凯路 Non-Executive Director
萧耀熙 Independent Non-Executive Director
阮添士 Independent Non-Executive Director
杨春 Independent Non-Executive Director
周国防 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-09-10.

About this page

This page shows LONGBIO-B (01779) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.